The roles of interleukin-1 receptor accessory protein in certain inflammatory conditions
(2022) In Immunology 166(1). p.38-46- Abstract
Interleukin-1 receptor accessory protein (IL-1RAcP) is a member of the immunoglobulin superfamily proteins consisting of soluble and membranous isoforms. IL-1RAcP plays an essential role in the signaling of the IL-1 family cytokines such as IL-1, IL-33 and IL-36, as well as tyrosine kinases FLT3 and C-Kit. IL-1RAcP generally initiates inflammatory signaling pathway through the recruitment of signaling mediators, including MYD88 and IRAK. Chronic inflammation following prolonged signaling of cytokine receptors is a critical process in the pathogenesis of many inflammatory disorders, including autoimmunity, obesity, psoriasis, type 1 diabetes, endometriosis, preeclampsia and Alzheimer's disease. Recently IL-1RAcP aberrant signaling has... (More)
Interleukin-1 receptor accessory protein (IL-1RAcP) is a member of the immunoglobulin superfamily proteins consisting of soluble and membranous isoforms. IL-1RAcP plays an essential role in the signaling of the IL-1 family cytokines such as IL-1, IL-33 and IL-36, as well as tyrosine kinases FLT3 and C-Kit. IL-1RAcP generally initiates inflammatory signaling pathway through the recruitment of signaling mediators, including MYD88 and IRAK. Chronic inflammation following prolonged signaling of cytokine receptors is a critical process in the pathogenesis of many inflammatory disorders, including autoimmunity, obesity, psoriasis, type 1 diabetes, endometriosis, preeclampsia and Alzheimer's disease. Recently IL-1RAcP aberrant signaling has been considered to play a central role in the pathogenesis of these chronic inflammatory diseases. Targeting IL-1RAcP signaling pathway that was recently considered in clinical trials related to malignancies also indicates its potential as therapeutic target for the inflammatory and autoimmune diseases. This review summarizes the molecular structure, components associated with IL-1RAcP signaling pathways, and their involvement in the pathogenesis of different inflammatory diseases. We will also discuss the effect of IL-1RAcP inhibition for treatment proposes.
(Less)
- author
- Zarezadeh Mehrabadi, Ali ; Aghamohamadi, Nazanin ; Khoshmirsafa, Majid ; Aghamajidi, Azin ; Pilehforoshha, Mohammad ; Massoumi, Ramin LU and Falak, Reza
- organization
- publishing date
- 2022
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- IL-1, IL-1 receptor accessory protein, Inflammation
- in
- Immunology
- volume
- 166
- issue
- 1
- pages
- 9 pages
- publisher
- Wiley-Blackwell
- external identifiers
-
- scopus:85126007688
- pmid:35231129
- ISSN
- 0019-2805
- DOI
- 10.1111/imm.13462
- language
- English
- LU publication?
- yes
- id
- 93587601-3ecd-434d-b4b0-b260477c2740
- date added to LUP
- 2022-04-22 16:02:16
- date last changed
- 2024-06-20 19:04:14
@article{93587601-3ecd-434d-b4b0-b260477c2740,
abstract = {{<p>Interleukin-1 receptor accessory protein (IL-1RAcP) is a member of the immunoglobulin superfamily proteins consisting of soluble and membranous isoforms. IL-1RAcP plays an essential role in the signaling of the IL-1 family cytokines such as IL-1, IL-33 and IL-36, as well as tyrosine kinases FLT3 and C-Kit. IL-1RAcP generally initiates inflammatory signaling pathway through the recruitment of signaling mediators, including MYD88 and IRAK. Chronic inflammation following prolonged signaling of cytokine receptors is a critical process in the pathogenesis of many inflammatory disorders, including autoimmunity, obesity, psoriasis, type 1 diabetes, endometriosis, preeclampsia and Alzheimer's disease. Recently IL-1RAcP aberrant signaling has been considered to play a central role in the pathogenesis of these chronic inflammatory diseases. Targeting IL-1RAcP signaling pathway that was recently considered in clinical trials related to malignancies also indicates its potential as therapeutic target for the inflammatory and autoimmune diseases. This review summarizes the molecular structure, components associated with IL-1RAcP signaling pathways, and their involvement in the pathogenesis of different inflammatory diseases. We will also discuss the effect of IL-1RAcP inhibition for treatment proposes.</p>}},
author = {{Zarezadeh Mehrabadi, Ali and Aghamohamadi, Nazanin and Khoshmirsafa, Majid and Aghamajidi, Azin and Pilehforoshha, Mohammad and Massoumi, Ramin and Falak, Reza}},
issn = {{0019-2805}},
keywords = {{IL-1; IL-1 receptor accessory protein; Inflammation}},
language = {{eng}},
number = {{1}},
pages = {{38--46}},
publisher = {{Wiley-Blackwell}},
series = {{Immunology}},
title = {{The roles of interleukin-1 receptor accessory protein in certain inflammatory conditions}},
url = {{http://dx.doi.org/10.1111/imm.13462}},
doi = {{10.1111/imm.13462}},
volume = {{166}},
year = {{2022}},
}